pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 19·1 min read
save

Study finds many Canadian medical societies lack robust conflict-of-interest policies

May 19, 2026·read at STAT ↗Negative

A new analysis of 68 Canadian medical societies shows that just under half have comprehensive conflict-of-interest policies. The researchers identified that 35 societies, or about 52%, do not address a set of nine essential activities.

The missing coverage includes areas such as clinical practice guidelines, research funding, society journals, continuing medical education, and relationships with pharmaceutical companies. Some societies also lack policies governing leadership or staff interactions.

The authors warn that these gaps could allow commercial bias to influence clinical guidance and educational programs, potentially affecting treatment decisions and patient outcomes.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Canadian medical societies lack sufficient conflict-of-interest policies, study finds”

read at STAT ↗
486 words · retrieved May 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
OzempicWegovy

related stories

  • May 7STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1BSTAT
  • May 6STAT+: Oregon hospitals won’t outsource to national physician chain after allSTAT
  • May 6STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’STAT
  • May 6Novo hikes guidance on Wegovy pill’s fast sales startBioPharma Dive
  • May 6STAT+: How a global effort to explore the ‘dark proteome’ is upending our understanding of human diseaseSTAT